ARCHIVES

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

This article is from The Cancer Letter archive.

Vol. 38 No. 32 | August 10, 2012

Download PDF Visit The Full Archive

Related Articles

Cancer Clinical Trials Approved By NCI Last Month Are Listed

November 29, 2002

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

October 9, 1987

Sausville to lead clinical research at Maryland.

December 5, 2003

Obama Executive Order Gives FDA Authority To Combat Drug Shortages

November 4, 2011

Breast Cancer Task Force to Issue New RFPs In July, September

July 9, 1976

In Brief: Congress Finished Spending Bill, Reagan Signs It; NCI Gets $1.402 Billion, a $174.5 Million Raise

October 24, 1986